Patents by Inventor Lingling Wei

Lingling Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250343015
    Abstract: An isolating switch body, an isolating switch, and a power distribution system are provided. The isolating switch body includes body modules, where each body module includes a plurality of layers of switch units which are stacked, the plurality of layers of switch units are connected through respective body rotating shafts, and a plurality of groups of body modules are spliced to form the isolating switch body; the body rotating shafts of the switch units are linked with an operating mechanism through a transmission mechanism in a first direction perpendicular to a stacking direction. The handle shaft is rotated to drive the operating mechanism to act, and then the body modules are driven through the transmission mechanism to achieve synchronous opening and closing.
    Type: Application
    Filed: July 18, 2025
    Publication date: November 6, 2025
    Inventors: Sheng'ai Li, Yipeng Yu, Weijian Peng, Li Ba, Mingxue Zhang, Jiajun Lu, Lingling Wei, Xinmei Liu
  • Patent number: 9186421
    Abstract: Use of low dose streptozocin in the preparation of an animal model for screening drugs for treatment of antoimmune type 1 diabetes is disclosed, in which streptozocin is administrated intravenously at a dose of 15-30 mg/kg per time for 5 days and administrated again on the 7th day and 14th day after last time of offering drug. A method for preparing rhesus monkey model of autoimmune type 1 diabetes and autoimmune type 1 diabetes animal model obtained are also disclosed.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: November 17, 2015
    Assignee: West China Hospital, Sichuan University
    Inventors: Yanrong Lu, Jingqiu Cheng, Shaoping Deng, Younan Chen, Bole Tian, Gang Mai, Yan Ren, Li Wang, Hongxia Li, Lingling Wei, Xi Jin, Chaofeng Qiao, Wensheng Zhang, Sirong He, Li Zeng
  • Publication number: 20130149733
    Abstract: Use of low dose streptozocin in the preparation of an animal model for screening drugs for treatment of antoimmune type 1 diabetes is disclosed, in which streptozocin is administrated intravenously at a dose of 15-30 mg/kg per time for 5 days and administrated again on the 7th day and 14th day after last time of offering drug. A method for preparing rhesus monkey model of autoimmune type 1 diabetes and autoimmune type 1 diabetes animal model obtained are also disclosed.
    Type: Application
    Filed: March 26, 2010
    Publication date: June 13, 2013
    Applicant: West China Hospital, Sichuan University
    Inventors: Yanrong Lu, Jingqiu Cheng, Shaoping Deng, Younan Chen, Bole Tian, Gang Mai, Yan Ren, Li Wang, Hongxia Li, Lingling Wei, Xi Jin, Chaofeng Qiao, Wensheng Zhang, Sirong He, Li Zeng